Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 7Recruiting 2Active not recruiting 2Completed 1

Sponsor Class

INDUSTRY 7OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Metastatic Non-small Cell Lung Cancers 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × lazertinib × Clear all
NCT05786430 2026-01-27

LUCAS

Yonsei University

Phase 2 Active not recruiting
87 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05299125 2025-10-01

AMIGO-1

Latin American Cooperative Oncology Group

Phase 2 Active not recruiting
54 enrolled
Thoracic

Metastatic Non-small Cell Lung Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡